J. Bamoulid

发表

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

A. Kazory, C. Courivaud, D. Ducloux, 2019, BMC Nephrology.

Influence of Fractalkine Receptor Gene Polymorphisms V249I-T280M on Cancer Occurrence After Renal Transplantation

M. Deschamps, P. Tiberghien, C. Borg, 2013, Transplantation.

Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients

P. Tiberghien, C. Borg, P. Saas, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Pretransplant Serum Vitamin D Levels and Risk of Cancer After Renal Transplantation

A. Kazory, C. Courivaud, G. Dumoulin, 2008, Transplantation.

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

G. Choukroun, C. Legendre, D. Vernerey, 2019, Trials.

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients

M. Deschamps, P. Tiberghien, P. Saas, 2011, Journal of Transplantation.

CD4 T Lymphopenia, Thymic Function, Homeostatic Proliferation and Late Complications Associated with Kidney Transplantation

P. Saas, B. Gaugler, C. Courivaud, 2013 .

Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation

P. Saas, B. Gaugler, C. Courivaud, 2015, Transplantation.

Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients.

C. Ferrand, P. Saas, C. Courivaud, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical Outcome of Patients With De Novo C1q-Binding Donor-Specific HLA Antibodies After Renal Transplantation

K. Budde, B. Rudolph, N. Lachmann, 2017, Transplantation.

Need for optimized immunosuppression in elderly kidney transplant recipients.

K. Budde, J. Bamoulid, L. Liefeldt, 2015, Transplantation reviews.

Impact of polyclonal antithymocyte globulins on kidney transplant outcomes in real-life: a propensity score analysis

P. Rieu, A. Heng, L. Frimat, 2019 .

Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2014, Journal of the American Society of Nephrology : JASN.

Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2013, The Journal of infectious diseases.

Subclinical Epstein–Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences

P. Saas, A. Coaquette, C. Courivaud, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunosuppression and Results in Renal Transplantation

K. Budde, A. Paliege, S. Brakemeier, 2016 .

Significant increase in 1-year posttransplant renal arterial index predicts graft loss.

B. Kastler, C. Courivaud, D. Ducloux, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study

P. Tiberghien, D. Vernerey, P. Saas, 2022, Frontiers in Immunology.

Immune phenotype predicts new onset diabetes after kidney transplantation.

P. Saas, C. Courivaud, S. Borot, 2019, Human immunology.

Antithymocytes globulins: Time to revisit its use in kidney transplantation?

P. Saas, C. Courivaud, D. Ducloux, 2018, International reviews of immunology.

Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients

N. Kamar, L. Frimat, P. Gatault, 2022, Kidney International Reports.

The inferior impact of antibody‐mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy

K. Budde, D. Schmidt, B. Rudolph, 2016, Clinical transplantation.

The need for minimization strategies: current problems of immunosuppression

K. Budde, S. Brakemeier, M. Dürr, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications

P. Saas, C. Courivaud, D. Ducloux, 2018, Immunity & ageing : I & A.

Advances in pharmacotherapy to treat kidney transplant rejection

K. Budde, N. Lachmann, A. Paliege, 2015, Expert opinion on pharmacotherapy.

G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation.

P. Tiberghien, E. Thervet, P. Saas, 2009, Transplantation.

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2005, Kidney international.

Renal Transplantation Obesity and Cardiac Risk after Kidney Transplantation: Experience at One Center and Comprehensive Literature Review. Transplantation 2008; 303–312 Pretransplant Serum Vitamin D Levels and Risk of Cancer after Renal Transplantation. Transplantation

M. Schnitzler, Dumoulin, K. Lentine, 2009 .

End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?

P. Saas, C. Courivaud, D. Ducloux, 2021, Frontiers in Medicine.

Pre‐transplant end‐stage renal disease‐related immune risk profile in kidney transplant recipients predicts post‐transplant infections

P. Rieu, L. Frimat, P. Saas, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins.

P. Tiberghien, C. Ferrand, P. Saas, 2011, Human immunology.

Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword.

P. Saas, C. Courivaud, D. Ducloux, 2017, Transplantation reviews.

ATG‐Induced Accelerated Immune Senescence: Clinical Implications in Renal Transplant Recipients

P. Rieu, P. Tiberghien, C. Ferrand, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins.

P. Rieu, A. Heng, L. Frimat, 2017, Transplant Immunology.

Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.

P. Rieu, A. Heng, L. Frimat, 2016, Kidney international.

A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib.

E. Deconinck, C. Ferrand, S. Hayette, 2013, Leukemia research reports.

Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantation.

F. Aubin, M. Deschamps, P. Tiberghien, 2010, The Journal of investigative dermatology.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

F. Petitprez, Z. Massy, C. Charasse, 2019, Journal of the American Society of Nephrology : JASN.

Influence of Cyclooxygenase‐2 (COX‐2) Gene Promoter Polymorphism −765 on Graft Loss After Renal Transplantation

M. Deschamps, P. Tiberghien, C. Ferrand, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects

K. Budde, P. Saas, S. Brakemeier, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants

P. Muret, Jennifer Lagoutte-Renosi, S. Davani, 2021, Journal of chemotherapy.

New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response

J. Pais de Barros, L. Lagrost, P. Saas, 2021, Frontiers in Immunology.

The case: a female with hyponatremia. Diagnosis: Postpartum panhypopituitarism (Sheehan syndrome).

A. Kazory, C. Courivaud, J. Bonneville, 2009, Kidney international.

Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation

P. Saas, C. Courivaud, D. Ducloux, 2020, Frontiers in Immunology.

Rheumatoid purpura associated with toxocariasis.

L. Millon, P. Humbert, J. Bamoulid, 2011, Canadian family physician Medecin de famille canadien.

Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2010, Journal of the American Society of Nephrology : JASN.

Is COVID-19 infection more severe in kidney transplant recipients?

N. Kamar, L. Frimat, P. Grimbert, 2020, American Journal of Transplantation.

Immune Monitoring of Kidney Recipients: Biomarkers to Appreciate Immunosuppression -Associated Complications

P. Saas, B. Gaugler, D. Ducloux, 2011 .

Posttransplant Immune Activation

P. Saas, C. Courivaud, D. Ducloux, 2017, Cell transplantation.

Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.

P. Tiberghien, C. Borg, C. Ferrand, 2011, Transplant immunology.

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation

P. Rieu, J. Pais de Barros, A. Heng, 2019, Front. Immunol..

Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients

C. Courivaud, D. Ducloux, J. Bamoulid, 2021, Clinical kidney journal.

Occurrence of severe COVID-19 in vaccinated transplant patients

N. Kamar, P. Gatault, H. François, 2021, Kidney International.

Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?

K. Budde, D. Schmidt, N. Lachmann, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications

P. Saas, C. Courivaud, D. Ducloux, 2018, Immunity & ageing : I & A.

IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2006, Journal of the American Society of Nephrology : JASN.

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients

C. Courivaud, D. Ducloux, J. Bamoulid, 2022, Journal of Infection.

An extension of the RITUX‐ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody‐mediated rejection after renal transplantation

N. Kamar, C. Pouteil‐Noble, P. Grimbert, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Description of an outbreak of hemorrhagic fever with renal syndrome in the southern Jura Mountains, France, in 2021.

P. Giraudoux, J. Reynes, C. Chirouze, 2023, Infectious diseases now.

Late Persistent Positive EBV Viral Load and Risk of Solid Cancer in Kidney Transplant Patients

A. Coaquette, C. Courivaud, D. Ducloux, 2017, Transplantation.